Switch theme
Sign up to access all valuation multiples
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
2006
2K+
LTM Revenue $635M
LTM EBITDA $18.1M
$4.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
iRhythm Technologies has a last 12-month revenue (LTM) of $635M and a last 12-month EBITDA of $18.1M.
In the most recent fiscal year, iRhythm Technologies achieved revenue of $592M and an EBITDA of -$74.1M.
iRhythm Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
See iRhythm Technologies valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $635M | XXX | $592M | XXX | XXX | XXX |
| Gross Profit | $438M | XXX | $408M | XXX | XXX | XXX |
| Gross Margin | 69% | XXX | 69% | XXX | XXX | XXX |
| EBITDA | $18.1M | XXX | -$74.1M | XXX | XXX | XXX |
| EBITDA Margin | 3% | XXX | -13% | XXX | XXX | XXX |
| EBIT | -$87.5M | XXX | -$115M | XXX | XXX | XXX |
| EBIT Margin | -14% | XXX | -19% | XXX | XXX | XXX |
| Net Profit | -$88.9M | XXX | -$113M | XXX | XXX | XXX |
| Net Margin | -14% | XXX | -19% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $227M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, iRhythm Technologies's stock price is $140.
iRhythm Technologies has current market cap of $4.5B, and EV of $4.7B.
See iRhythm Technologies trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4.7B | $4.5B | XXX | XXX | XXX | XXX | $-2.86 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, iRhythm Technologies has market cap of $4.5B and EV of $4.7B.
iRhythm Technologies's trades at 7.9x EV/Revenue multiple, and -63.4x EV/EBITDA.
Equity research analysts estimate iRhythm Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
iRhythm Technologies has a P/E ratio of -50.4x.
See valuation multiples for iRhythm Technologies and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4.5B | XXX | $4.5B | XXX | XXX | XXX |
| EV (current) | $4.7B | XXX | $4.7B | XXX | XXX | XXX |
| EV/Revenue | 7.4x | XXX | 7.9x | XXX | XXX | XXX |
| EV/EBITDA | 260.2x | XXX | -63.4x | XXX | XXX | XXX |
| EV/EBIT | -53.7x | XXX | -40.9x | XXX | XXX | XXX |
| EV/Gross Profit | 10.7x | XXX | n/a | XXX | XXX | XXX |
| P/E | -50.4x | XXX | -39.6x | XXX | XXX | XXX |
| EV/FCF | -74.4x | XXX | -103.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialiRhythm Technologies's last 12 month revenue growth is 17%
iRhythm Technologies's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.3M for the same period.
iRhythm Technologies's rule of 40 is -2% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
iRhythm Technologies's rule of X is 46% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for iRhythm Technologies and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 17% | XXX | 17% | XXX | XXX | XXX |
| EBITDA Margin | 3% | XXX | -13% | XXX | XXX | XXX |
| EBITDA Growth | 306% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -2% | XXX | 5% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 46% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 88% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
iRhythm Technologies acquired XXX companies to date.
Last acquisition by iRhythm Technologies was XXXXXXXX, XXXXX XXXXX XXXXXX . iRhythm Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was iRhythm Technologies founded? | iRhythm Technologies was founded in 2006. |
| Where is iRhythm Technologies headquartered? | iRhythm Technologies is headquartered in United States of America. |
| How many employees does iRhythm Technologies have? | As of today, iRhythm Technologies has 2K+ employees. |
| Who is the CEO of iRhythm Technologies? | iRhythm Technologies's CEO is Mr. Quentin S. Blackford. |
| Is iRhythm Technologies publicy listed? | Yes, iRhythm Technologies is a public company listed on NAS. |
| What is the stock symbol of iRhythm Technologies? | iRhythm Technologies trades under IRTC ticker. |
| When did iRhythm Technologies go public? | iRhythm Technologies went public in 2016. |
| Who are competitors of iRhythm Technologies? | Similar companies to iRhythm Technologies include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of iRhythm Technologies? | iRhythm Technologies's current market cap is $4.5B |
| What is the current revenue of iRhythm Technologies? | iRhythm Technologies's last 12 months revenue is $635M. |
| What is the current revenue growth of iRhythm Technologies? | iRhythm Technologies revenue growth (NTM/LTM) is 17%. |
| What is the current EV/Revenue multiple of iRhythm Technologies? | Current revenue multiple of iRhythm Technologies is 7.4x. |
| Is iRhythm Technologies profitable? | Yes, iRhythm Technologies is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of iRhythm Technologies? | iRhythm Technologies's last 12 months EBITDA is $18.1M. |
| What is iRhythm Technologies's EBITDA margin? | iRhythm Technologies's last 12 months EBITDA margin is 3%. |
| What is the current EV/EBITDA multiple of iRhythm Technologies? | Current EBITDA multiple of iRhythm Technologies is 260.2x. |
| What is the current FCF of iRhythm Technologies? | iRhythm Technologies's last 12 months FCF is -$63.2M. |
| What is iRhythm Technologies's FCF margin? | iRhythm Technologies's last 12 months FCF margin is -10%. |
| What is the current EV/FCF multiple of iRhythm Technologies? | Current FCF multiple of iRhythm Technologies is -74.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
